A review of high-risk prostate cancer and the role of neo-adjuvant and adjuvant therapies
โ Scribed by Joshua R. Gonzalez; Melissa A. Laudano; Tara R. McCann; James M. McKiernan; Mitchell C. Benson
- Publisher
- Springer-Verlag
- Year
- 2008
- Tongue
- English
- Weight
- 219 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0724-4983
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
This review of the current literature related to the use of chemo-and adjuvant chemotherapy in colorectal carcinoma emphasizes the present dilemma in caring for people affected with this disorder. Adjuvant chemotherapy using combinations of 5-fluorouracil and levamisole clearly prolong survival, alb
Because of the uncertainties regarding the efficacy of postoperative radiation therapy for early prostate cancer, treatment strategies following radical prostatectomy include: (1) observation alone in high-risk patients, (2) adjuvant radiation therapy (PSA undetectable) in high-risk patients, or (3)
## Abstract ## BACKGROUND Patients with T~3~ and/or N~1~ prostate carcinoma have poor cure rates. The authors sought to improve the relapse free, cancer specific survival of these patients by adding chemohormonal therapy to radiation. ## METHODS Twenty five men with clinical Stage III positive s